Variation in Transcriptional Regulation of Cyclin Dependent Kinase Inhibitor P21waf1/cip1 Among Human Bronchogenic Carcinomas

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2005 Jul 15

PMID 16014176

Citations 2

Authors

Michael W Harr

Timothy G Graves

Erin L Crawford

Kristy A Warner

Cheryl A M Reed

James C Willey

Affiliations

Soon will be listed here.

Abstract

Background: Cell proliferation control depends in part on the carefully ordered regulation of transcription factors. The p53 homolog p73, contributes to this control by directly upregulating the cyclin dependent kinase inhibitor, p21waf1/cip1. E2F1, an inducer of cell proliferation, directly upregulates p73 and in some systems upregulates p21 directly. Because of its central role in controlling cell proliferation, upregulation of p21 has been explored as a modality for treating bronchogenic carcinoma (BC). Improved understanding of p21 transcriptional regulation will facilitate identification of BC tissues that are responsive to p21-directed therapies. Toward this goal, we investigated the role that E2F1 and p73 each play in the transcriptional regulation of p21.

Results: Among BC samples (N = 21) p21 transcript abundance (TA) levels varied over two orders of magnitude with values ranging from 400 to 120,000 (in units of molecules/106 molecules beta-actin). The p21 values in many BC were high compared to those observed in normal bronchial epithelial cells (BEC) (N = 18). Among all BC samples, there was no correlation between E2F1 and p21 TA but there was positive correlation between E2F1 and p73alpha (p < 0.001) TA. Among BC cell lines with inactivated p53 and wild type p73 (N = 7) there was positive correlation between p73alpha and p21 TA (p < 0.05). Additionally, in a BC cell line in which both p53 and p73 were inactivated (H1155), E2F1 TA level was high (50,000), but p21 TA level was low (470). Transiently expressed exogenous p73alpha in the BC cell line Calu-1, was associated with a significant (p < 0.05) 90% increase in p21 TA and a 20% reduction in E2F1 TA. siRNA mediated reduction of p73 TA in the N417 BC cell line was associated with a significant reduction in p21 TA level (p < 0.01).

Conclusion: p21 TA levels vary considerably among BC patients which may be attributable to 1) genetic alterations in Rb and p53 and 2) variation in TA levels of upstream transcription factors E2F1 and p73. Here we provide evidence that p73 upregulates p21 TA in BC tissues and upregulated p21 TA may result from E2F1 upregulation of p73 but not from E2F1 directly.

Citing Articles

Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells.

Zhang X, Crawford E, Blomquist T, Khuder S, Yeo J, Levin A Physiol Genomics. 2016; 48(7):537-43.

PMID: 27235448 PMC: 4967224. DOI: 10.1152/physiolgenomics.00021.2016.

Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.

Graves T, Harr M, Crawford E, Willey J Mol Cancer. 2006; 5:1.

PMID: 16403226 PMC: 1368995. DOI: 10.1186/1476-4598-5-1.

References

Rodicker F, Stiewe T, Zimmermann S, Putzer B . Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction. Cancer Res. 2001; 61(19):7052-5. View

Wistuba I, Gazdar A, Minna J . Molecular genetics of small cell lung carcinoma. Semin Oncol. 2001; 28(2 Suppl 4):3-13. View

Yang A, Kaghad M, Caput D, McKeon F . On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 2002; 18(2):90-5. DOI: 10.1016/s0168-9525(02)02595-7. View

Olivier M, Eeles R, Hollstein M, Khan M, Harris C, Hainaut P . The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat. 2002; 19(6):607-14. DOI: 10.1002/humu.10081. View

Kartasheva N, Contente A, Roth J, Dobbelstein M . p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene. 2002; 21(31):4715-27. DOI: 10.1038/sj.onc.1205584. View

Stevaux O, Dyson N . A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol. 2002; 14(6):684-91. DOI: 10.1016/s0955-0674(02)00388-5. View

Warner K, Crawford E, Zaher A, Coombs R, Elsamaloty H, Roshong-Denk S . The c-myc x E2F-1/p21 interactive gene expression index augments cytomorphologic diagnosis of lung cancer in fine-needle aspirate specimens. J Mol Diagn. 2003; 5(3):176-83. PMC: 1907329. DOI: 10.1016/S1525-1578(10)60470-9. View

Huqun , Endo Y, Xin H, Takahashi M, Nukiwa T, Hagiwara K . A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function. Cancer Sci. 2003; 94(8):718-24. PMC: 11160092. DOI: 10.1111/j.1349-7006.2003.tb01508.x. View

Vassilev L, Vu B, Graves B, Carvajal D, Podlaski F, Filipovic Z . In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004; 303(5659):844-8. DOI: 10.1126/science.1092472. View

10.

Scacheri P, Rozenblatt-Rosen O, Caplen N, Wolfsberg T, Umayam L, Lee J . Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A. 2004; 101(7):1892-7. PMC: 357023. DOI: 10.1073/pnas.0308698100. View

11.

Lechner J, Haugen A, McClendon I, Shamsuddin A . Induction of squamous differentiation of normal human bronchial epithelial cells by small amounts of serum. Differentiation. 1984; 25(3):229-37. DOI: 10.1111/j.1432-0436.1984.tb01361.x. View

12.

Willey J, Moser Jr C, Lechner J, Harris C . Differential effects of 12-O-tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells. Cancer Res. 1984; 44(11):5124-6. View

13.

Kovesdi I, Reichel R, Nevins J . Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 1986; 45(2):219-28. DOI: 10.1016/0092-8674(86)90386-7. View

14.

Minna J, Battey J, Birrer M, Brooks B, Cuttitta F, Degreve J . Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer. Princess Takamatsu Symp. 1986; 17:109-22. View

15.

Pardee A . G1 events and regulation of cell proliferation. Science. 1989; 246(4930):603-8. DOI: 10.1126/science.2683075. View

16.

Chellappan S, Hiebert S, Mudryj M, Horowitz J, Nevins J . The E2F transcription factor is a cellular target for the RB protein. Cell. 1991; 65(6):1053-61. DOI: 10.1016/0092-8674(91)90557-f. View

17.

Kato J, Matsushime H, Hiebert S, Ewen M, Sherr C . Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993; 7(3):331-42. DOI: 10.1101/gad.7.3.331. View

18.

Celi F, Zenilman M, Shuldiner A . A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res. 1993; 21(4):1047. PMC: 309252. DOI: 10.1093/nar/21.4.1047. View

19.

Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J . Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci U S A. 1993; 90(8):3685-9. PMC: 46366. DOI: 10.1073/pnas.90.8.3685. View

20.

Ewen M, Sluss H, Sherr C, Matsushime H, Kato J, Livingston D . Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 1993; 73(3):487-97. DOI: 10.1016/0092-8674(93)90136-e. View